EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Role of Blood-based Biomarkers in Sarcomas

David S Shulman, Brian D Crompton

Hematology/Oncology Clinics of North America · 2025

DOI: 10.1016/j.hoc.2025.04.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2025. Verfasst von David S Shulman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA. Electronic addr…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Circulating Tumor DNA, Sarcoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We assess the emerging role of liquid biopsies, particularly circulating tumor DNA (ctDNA), in sarcoma management. Preliminary studies suggest that ctDNA has multiple potential applications including, early detection in patients with cancer predisposition syndromes, diagnosis, prognostication, therapy selection, and monitoring treatment response. Among patients with gastrointestinal stromal tumors, studies have demonstrated the capacity for identification of clinically relevant resistance mutations. In other sarcoma subtypes such as Ewing sarcoma and osteosarcoma, early findings indicate that ctDNA levels might correlate with tumor burden and outcomes, potentially aiding in risk stratification. Clinical utility has not been established for these applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCirculating Tumor DNASarcomaHumansLiquid BiopsyPrognosis

Stichwörter der Autor:innen

BiomarkerCTCLiquid biopsySarcomactDNA

Substanzen

Biomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA. Electronic address: David_Shulman@dfci.harvard.edu.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Boston Children's Hospital, Boston, MA 02115, USA; Cancer Program, Broad Institute of…

Zitieren

APA

Shulman, D. S., & Crompton, B. D. (2025). Emerging Role of Blood-based Biomarkers in Sarcomas. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2025.04.002

Vancouver

Shulman DS, Crompton BD. Emerging Role of Blood-based Biomarkers in Sarcomas. Hematology/Oncology Clinics of North America. 2025. doi:10.1016/j.hoc.2025.04.002

BibTeX
@article{Shulman2025,
  author = {Shulman, David S and Crompton, Brian D},
  title = {Emerging Role of Blood-based Biomarkers in Sarcomas},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2025},
  doi = {10.1016/j.hoc.2025.04.002}
}
Kostenlos starten →